Blood plasma donated by people who have recovered from COVID-19 may help hospitalized patients with the virus, a new study led by researchers at NYU Grossman School of Medicine indicates.
The peer-reviewed Original Investigation published by the JAMA Network on January 25, 2022, showed that among 2,341 patients, those who received an injection of convalescent plasma soon after hospitalization were 15% less likely to die within a month from COVID-19 than those who did not receive convalescent plasma or those who received an inactive saline placebo.
Convalescent Plasma Benefits Certain COVID-19 Patients
Casirivimab + Imdevimab Prevents Progression to Symptomatic COVID-19
For asymptomatic SARS-CoV-2-positive individuals living with infected household contact, combo cuts incidence of symptomatic COVID-19
Children’s Hospital Admissions Reduced After March 2020
Fewer hospital admissions reported for respiratory, severe invasive, and vaccine-preventable infections
~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure
Three-month survival 95.6 percent among patients who underwent lung transplant during August 2020 to September 2021
Booster Shots More Effective During Omicron Emergence Period
And vaccine effectiveness lower during omicron with receipt of two doses, but higher after booster dose
More Than 1 Million U.S. Children Diagnosed With COVID-19 in Single Week
Since the start of the pandemic, more than 10.6 million children have tested positive for COVID-19
Biden Administration Withdraws Vaccine Mandate for Large Employers
Supreme Court said mandate went too far in imposing such a sweeping requirement on employers
Enforceable Employer COVID-19 Vaccine Mandate Withdrawn
The U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) today announced it is withdrawing the enforceable COVID-19 vaccination and testing emergency temporary standard (ETS).
The ETS was issued on November. 5, 2021, to protect unvaccinated employees of large employers with 100 or more employees from workplace exposure to the SARS-CoV-2 coronavirus.
This OSHA action becomes effective in the Federal Register on January 26, 2022.
No Evidence of Malignant, Sustained Arrhythmias Seen After COVID-19
Palpitations common, but corresponded with sinus rhythm or sinus tachycardia
Pfizer Begins Testing COVID-19 Vaccine Targeted to Omicron
New U.S. study will assess the updated, omicron-targeted vaccine for use as a booster or for primary vaccinations